HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CD74
CD74 molecule
Chromosome 5 · 5q33.1
NCBI Gene: 972Ensembl: ENSG00000019582.18HGNC: HGNC:1697UniProt: P04233
217PubMed Papers
20Diseases
2Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Trending
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
cytokine bindingamyloid-beta bindingcytokine receptor activityprotein bindingnon-small cell lung carcinomaneoplasmcancerlung adenocarcinoma
✦AI Summary

CD74 (MHC class II invariant chain) is a non-polymorphic type II transmembrane glycoprotein with diverse immune and pathological functions beyond its classical role as an MHC class II chaperone 1. Primary function: CD74 stabilizes cathepsin L conformation and maintains pools of mature enzyme in endocytic compartments of antigen-presenting cells 2. Mechanism: CD74 serves as a high-affinity cell membrane receptor for macrophage migration inhibitory factor (MIF) and participates in MHC class II protein trafficking 1. Activation of the CD74/CD44 receptor complex triggers multiple intracellular signaling cascades including ERK1/2, PI3K-Akt, NFκB, and AMPK pathways 1. Disease relevance: CD74 regulates T-cell and B-cell development, dendritic cell motility, and macrophage inflammation, with documented roles in liver fibrosis, type I diabetes, and systemic lupus erythematosus 1. Clinical significance: High CD74 expression in tumor-infiltrating cells identifies constitutive interferon-high immunophenotypes predicting immunotherapy response in colorectal cancer, independent of MMR status 3. CD74 supports tumor-infiltrating regulatory T cell accumulation and suppressive function 4. Blocking tumor-associated macrophage-derived CD74 enhances neoadjuvant chemotherapy efficacy with PD-1 blockade in cervical cancer 5, and MIF-CD74 axis inhibition augments radiotherapy response in brain metastasis 6.

Sources cited
1
CD74 is an MHC class II invariant chain with diverse biological functions including MIF receptor activity and role in inflammatory diseases
PMID: 27752708
2
CD74 p41 isoform has antiviral activity against SARS-CoV-2 and other coronaviruses through cathepsin-mediated mechanisms
PMID: 32855215
3
High CD74 expression identifies constitutive interferon-high immunophenotype predicting immunotherapy response in colorectal cancer
PMID: 39824178
4
CD74 supports accumulation and suppressive function of tumor-infiltrating regulatory T cells
PMID: 38702311
5
Blocking tumor-associated macrophage-derived CD74 enhances phagocytosis and improves neoadjuvant chemotherapy efficacy with PD-1 blockade
PMID: 39107132
6
Blocking MIF-CD74 axis promotes microglia M1 polarization and augments radiotherapy efficacy for brain metastasis
PMID: 38685050
Disease Associationsⓘ20
non-small cell lung carcinomaOpen Targets
0.62Moderate
neoplasmOpen Targets
0.42Moderate
cancerOpen Targets
0.42Moderate
lung adenocarcinomaOpen Targets
0.38Weak
squamous cell lung carcinomaOpen Targets
0.38Weak
lymphoid neoplasmOpen Targets
0.37Weak
acinar lung adenocarcinomaOpen Targets
0.37Weak
chronic lymphocytic leukemiaOpen Targets
0.30Weak
acute myeloid leukemiaOpen Targets
0.30Weak
diffuse large B-cell lymphomaOpen Targets
0.29Weak
head and neck squamous cell carcinomaOpen Targets
0.29Weak
gastric adenocarcinomaOpen Targets
0.28Weak
lung carcinomaOpen Targets
0.28Weak
colon adenocarcinomaOpen Targets
0.28Weak
small cell lung carcinomaOpen Targets
0.28Weak
gastric carcinomaOpen Targets
0.28Weak
bladder transitional cell carcinomaOpen Targets
0.28Weak
cervical squamous cell carcinomaOpen Targets
0.28Weak
clear cell renal carcinomaOpen Targets
0.28Weak
breast carcinomaOpen Targets
0.28Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets2
MILATUZUMABPhase I/II
HLA-DR antigens-associated invariant chain antagonist
chronic lymphocytic leukemia
REPOTRECTINIBApproved
NT-3 growth factor receptor inhibitor
non-small cell lung carcinoma
Related Genes
CD44Protein interaction100%HLA-DRAProtein interaction100%HLA-DQB1Protein interaction100%FAUProtein interaction100%HLA-DRB1Protein interaction100%CXCR4Protein interaction99%
Tissue Expression6 tissues
Lung
100%
Bone Marrow
52%
Heart
25%
Liver
14%
Brain
11%
Ovary
8%
Gene Interaction Network
Click a node to explore
CD74CD44HLA-DRAHLA-DQB1FAUHLA-DRB1CXCR4
PROTEIN STRUCTURE
Preparing viewer…
PDB4X5W · 1.34 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.85LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.57 [0.40–0.85]
RankingsWhere CD74 stands among ~20K protein-coding genes
  • #1,906of 20,598
    Most Researched217 · top 10%
  • #856of 1,025
    FDA-Approved Drug Targets1
  • #7,355of 17,882
    Most Constrained (LOEUF)0.85
Genes detectedCD74
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
The biological function and significance of CD74 in immune diseases.
PMID: 27752708
Inflamm Res · 2017
1.00
2
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer.
PMID: 39824178
Cancer Cell · 2025
0.90
3
Spatial Isoforms Reveal the Mechanisms of Metastasis.
PMID: 39312471
Adv Sci (Weinh) · 2024
0.80
4
CD74 is a functional MIF receptor on activated CD4
PMID: 38992165
Cell Mol Life Sci · 2024
0.80
5
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
PMID: 36134665
JCI Insight · 2022
0.70